![Kasper Osvald Thorkilsen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kasper Osvald Thorkilsen
Public Communications Contact bij Vivostat A/S
Profiel
Kasper Osvald Thorkilsen currently works in product marketing at Vivostat A and currently holds the position of Manager-Product Marketing at the same company.
Actieve functies van Kasper Osvald Thorkilsen
Bedrijven | Functie | Begin |
---|---|---|
Vivostat A/S
![]() Vivostat A/S Medical SpecialtiesHealth Technology Vivostat A/S provides cardiac, thoracic and orthopaedic surgery medical devices. It offers vivostat system, an automated system for the on-site preparation and application of patient-derived fibrin sealant or platelet rich fibrin. Its products include Vivostat autologous fibrin sealant for various settings in surgical areas, transfusion centers, or blood banks and Vivostat platelet rich fibrin, which utilizes the patient's own blood to derive either a surgical sealant to prevent and stop bleedings, or a gel with a high concentration of growth factors that stimulates the healing of chronic wounds, as well as provides application devices. The compnay was founded in 2001 by Tom Bjerg Lauritzen and Niels Hvid and is headquartered in Alleroed, Denmark. | Public Communications Contact | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Vivostat A/S
![]() Vivostat A/S Medical SpecialtiesHealth Technology Vivostat A/S provides cardiac, thoracic and orthopaedic surgery medical devices. It offers vivostat system, an automated system for the on-site preparation and application of patient-derived fibrin sealant or platelet rich fibrin. Its products include Vivostat autologous fibrin sealant for various settings in surgical areas, transfusion centers, or blood banks and Vivostat platelet rich fibrin, which utilizes the patient's own blood to derive either a surgical sealant to prevent and stop bleedings, or a gel with a high concentration of growth factors that stimulates the healing of chronic wounds, as well as provides application devices. The compnay was founded in 2001 by Tom Bjerg Lauritzen and Niels Hvid and is headquartered in Alleroed, Denmark. | Health Technology |